1y return+166.9%S&P 500 +20.9%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since September 30, 2024: $173 against $130 in the S&P 500.2
venBio Partners LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| Pharvaris N VCUSIP N69605108 | $160.6M | 30.9% | |
| PBLSParabilis Medicines Inc | $144.1M | 27.8% | New |
| ALMSAlumis Inc | $127.4M | 24.5% | |
| ACHVAchieve Life Science Inc | $38.6M | 7.4% | New |
| ALXOAlx Oncology Hldgs Inc | $26.7M | 5.1% | |
| HRMYHarmony Biosciences Hldgs In | $17.2M | 3.3% | −3.5% |
| LYELLyell Immunopharma Inc | $4.7M | 0.9% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| ALMSAlumis Inc | June 30, 2024 | +111.6% | $127.4M |
| LYELLyell Immunopharma Inc | June 30, 2025 | +58.9% | $4.7M |
| Pharvaris N VCUSIP N69605108 | March 31, 2021 | +23.6% | $160.6M |
| HRMYHarmony Biosciences Hldgs In | September 30, 2020 | +7.4% | $17.2M |
Sold off last quarter
- ARTVArtiva Biotherapeutics Inc was $3.4M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +22.0% | +14.8% |
| March 31, 2026 | +28.0% | −4.6% |
| December 31, 2025 | +26.2% | +2.4% |
| September 30, 2025 | +35.4% | +7.8% |
| June 30, 2025 | −5.0% | +10.5% |
| March 31, 2025 | −21.7% | −4.6% |
| December 31, 2024 | −12.9% | +2.1% |
| June 30, 2024 | −31.0% | +4.0% |
| September 30, 2023 | −18.0% | −3.6% |
| June 30, 2023 | +25.0% | +8.3% |
| March 31, 2023 | −30.9% | +7.0% |
| December 31, 2022 | −0.7% | +7.1% |
| September 30, 2022 | +32.2% | −5.3% |
| June 30, 2022 | −19.5% | −16.5% |
| March 31, 2022 | −14.5% | −4.9% |
| September 30, 2021 | +22.1% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: venBio Partners LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1776382&type=13F-HR&dateb=&owner=include&count=40CIK 1776382
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1776382/000090514826003741/Filed August 14, 2026 · accession 0000905148-26-003741